Investor's question, Re: drug development procedures/strategies,HIV

BillS169 bills169 at aol.com
Tue Mar 26 09:17:08 EST 1996

I am a private investor talking with an independent scientist who has an
idea for research concerning development of an anti-infective small
molecule for HIV treatment. As a layman, my question centers on how
mainstream and/or logical the proposed research approach is. The approach
involves further study of a compound which is known to *increase* HIV
infectivity, and then to do analogs from SAR's to chemically work away
from the receptor sites that are believed to be key in the infection
process. Any thoughts from those who understand drug developement process
would be appreciated.

More information about the Immuno mailing list

Send comments to us at biosci-help [At] net.bio.net